Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Near Patient Study of the OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test in Oral Fluid and Fingerstick Whole Blood

NCT04810559 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT04810559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04810559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Near Patient Study of the OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test in Oral Fluid and Fingerstick Whole Blood
Lead sponsor
Unity Health Toronto
Phase
Not applicable
Overall status
Completed
Start date
July 29, 2021
Completion date
June 30, 2024
Enrollment
600 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections, hiv testing